MC# 20-41 A Phase Ia/Ib Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY159 as a Single Agent and In Combination with Pembrolizumab in Subjects with Advanced Solid Tumors
Mary Crowley Cancer Research is a specialized clinical research center that offers access to new investigational therapies through the administration of Phase I and II clinical trials. Our approach is to rapidly advance the discovery of potential new therapies and positively impact the care of cancer patients in their lifetime.
Personalized approach to cancer research
Clinical trials are matched to molecular information found within each cancer patient
Qualified Physician Investigators add to the understanding of what drives cancer and create innovative research applications that attack these drivers
Patient-centric focus brings the newest clinical trial options to patients at a rapid pace